The role of AGE–RAGE system in the development of diabetic nephropathy in vivo

International Congress Series

Volumn 1245, Issue C, 2002, Pages 45-50

  Yamamoto, Yasuhiko ^a   Kato, Ichiro ^b   Doi, Toshio ^c   Yonekura, Hideto ^a   Ohashi, Seiji ^c   Takeuchi, Masayoshi ^d   Watanabe, Takuo ^a   Sakurai, Shigeru ^a   Yasui, Kiyoshi ^a   Petrova, Ralica G ^a   Abedin, Md Joynal ^a   Li, Hui ^a   Azadur Rahman, A ^a   Takasawa, Shin ^b   Okamoto, Hiroshi ^b   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

Author keywords

Diabetes; Diabetic nephropathy; Glycation; RAGE; Transgenic mouse

Indexed keywords

EID: 84880996437     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(02)00996-2     Document Type: Article

References (18)

1. Brownlee, M., Cerami, A., Vlassara, H., Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318 (1988), 1315–1321.
2. Schmidt, A.M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., Clauss, M., et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267 (1992), 14987–14997.
3. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C., Elliston, K., Stern, D., Shaw, A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992), 14998–15004.
4. Yamagishi, S., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M., et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J. Biol. Chem. 272 (1997), 8723–8730.
5. Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., Yamamoto, H., Advanced glycation end products inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41 (1998), 1435–1441.
6. Yamagishi, S., Hsu, C.C., Taniguchi, M., Harada, S., Yamamoto, Y., Ohsawa, K., Kobayashi, K., Yamamoto, H., Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. Biochem. Biophys. Res. Commun. 213 (1995), 681–687.
7. Tsuji, H., Iehara, N., Masegi, T., Imura, M., Ohkawa, J., Arai, H., Ishii, K., Kita, T., Doi, T., Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells. Biochem. Biophys. Res. Commun. 245 (1998), 583–588.
8. Park, L., Raman, K.G., Lee, K.J., Lu, Y., Ferran, L.J. Jr., Chow, W.S., Stern, D., Schmidt, A.M., Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat. Med. 4 (1998), 1025–1031.
9. Vlassara, H., Striker, L.J., Teichberg, S., Fuh, H., Li, Y.M., Steffes, M., Advanced glycosylation end products induce glomerular sclerosis and albuminuria in normal rats. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 11704–11708.
10. Ronicke, V., Risau, W., Breier, G., Characterization of the endothelium-specific murine growth factor receptor-2 (Flk-1) promoter. Circ. Res. 79 (1996), 277–285.
11. Takamura, T., Kato, I., Kimura, N., Nakazawa, T., Yonekura, H., Takasawa, S., Okamoto, H., Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic β cells develop insulin-dependent diabetes without insulitis. J. Biol. Chem. 273 (1998), 2493–2496.
12. Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S., Sakurai, S., Takasawa, S., Okamoto, H., Yamamoto, H., Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108 (2001), 261–268.
13. Takeuchi, M., Makita, Z., Yanagisawa, K., Kameda, Y., Koike, T., Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol. Med. 5 (1999), 393–405.
14. Doi, T., Hattori, M., Agodoa, L.Y., Sato, T., Yoshida, H., Striker, L.J., Striker, G.E., Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab. Invest. 63 (1990), 204–212.
15. Doi, T., Striker, L.J., Gibson, C.C., Agodoa, L.Y., Brinster, R.L., Striker, G.E., Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-1. Relationship between increased glomerular size and mesangial sclerosis. Am. J. Pathol. 137 (1990), 541–552.
16. Kim, S., Kawamura, M., Wanibuchi, H., Ohta, K., Hamaguchi, A., Omura, T., Yukimura, T., Miura, K., Iwao, H., Angiotensin II type 1 receptor blockade inhibits the expression of immediate–early genes and fibronectin in rat injured artery. Circulation 92 (1995), 88–95.
17. Mogensen, C.E., Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42 (1999), 263–285.
18. Velasquez, M.T., Kimmel, P.L., Michaelis, O.E. IV, Animal models of spontaneous diabetic kidney disease. FASEB J. 4 (1990), 2850–2859.